The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency cited ...

FDA warning on topical finasteride: The FDA issued a warning about the topical form of finasteride (generic Propecia), often sold by telehealth companies, due to reports of serious side effects ...

There’s a widely-used hair loss drug that’s causing alarm at the Food and Drug Administration, and now the federal agency is warning consumers. The FDA says it has become aware of reports of adverse ...

The FDA is warning about a topical spray version of finasteride, a drug often sold online by telehealth companies. Adobe stock/HealthDay A quick spray of medication might seem like an easy way to get ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? It's caused some alarm—and confusion. For a long time now, the most common ...

The EU drug regulator, the European Medicines Agency, on Thursday confirmed suicidal ideation (suicidal thoughts) as a side effect of finasteride, a treatment indicated for hair loss due to male ...

Finasteride, a common hair-loss drug, has long been tied to depression and suicide, but regulators ignored the warnings. Prof. Mayer Brezis’s review exposes global data showing psychiatric harm and a ...

This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). Millions of men undergoing hair ...

Alpha-1 adrenergic antagonists produce greater improvement in voiding symptoms and urinary flow rates than finasteride alone. No additive or synergistic effects have been proven when terazosin was ...

The 24.8% relative risk reduction in prostate cancer seen in the finasteride arm prompted the early termination of the study on February 21, 2003, 15 months before its anticipated completion. While ...